Collectively, these data demonstrate that PRMT1 is critical for sustaining Rbm15-MKL1-initiated leukemia in mice, and pharmacological targeting of PRMT1 represents an effective strategy for treating leukemia. The gene discussed is RBM15; the disease is leukemia.